Laskow-Pooley David 5
5 · Marker Therapeutics, Inc. · Filed Feb 12, 2021
Insider Transaction Report
Form 5
Laskow-Pooley David
Director
Transactions
- Award
Common Stock
2020-05-19+17,022→ 42,565 total
Footnotes (1)
- [F1]Represents the portion of the annual board retainer for each non-employee director payable in immediately vested common stock under the Company's 2014 Omnibus Stock Ownership Plan, as amended and based on the closing price of $2.35 per share, on the day immediately preceding the date of the Company's 2019 annual meeting.